Peer-reviewed veterinary case report
Deducing the bioactive face of hydantoin anticonvulsant drugs using NMR spectroscopy.
- Journal:
- The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
- Year:
- 2008
- Authors:
- Tiedje, Kathryn E & Weaver, Donald F
- Affiliation:
- Department of Chemistry · Canada
Abstract
BACKGROUND: The general purpose of this study was to deduce the geometry of the bioactive face (pharmacophore) for the hydantoin class of anticonvulsants. METHODS: Six hydantoin analogs, selected as probes of hydantoin structure, were synthesized. Nuclear magnetic resonance spectroscopy and molecular modelling calculations were used to determine the geometric relationship between the aromatic group and the amide group in the hydantoin pharmacophore. RESULTS: In accord with both theoretical and experimental results, the biologically inactive hydantoin analogs containing a benzyl substituent existed in a folded conformation with the benzene flopped over the hydantoin ring. Conversely the biologically active hydantoins had a phenyl ring extended away from the hydantoin ring. CONCLUSIONS: The bioactive face for hydantoins consists of a N(H)-C(=O)-X-phenyl molecular fragment, where X is a carbon or nitrogen atom and where the distance between the centre of the amide bond and the centroid of the phenyl ring is 4.3 A.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/18574940/